Synopsis ​SigTuple has raised about $40. 8 million in funding so far, and is backed by the likes of Accel Partners, Chiratae Ventures, Pi Ventures and Flipkart co-founder Binny Bansal. ETtech The startup will use the new capital to drive geographical expansion, expand its product portfolio and support regulatory clearances (Illustration: Rahul Awasthi) Healthcare startup SigTuple has raised Rs 34. 5 crore in funding led by existing investors Endiya Partners and Accel , with participation from a few strategic leaders from the healthcare sector. The startup will use the capital to drive geographical expansion, expand its product portfolio and support regulatory clearances. SigTuple has raised about $40. 8 million in funding so far, and is backed by the likes of Accel Partners, Chiratae Ventures, Pi Ventures and Flipkart co-founder Binny Bansal. “The last one year has been truly transformative for the organisation, with major product improvements, new product additions and, most importantly, strong customer traction,” said SigTuple chief executive officer Tathagato Rai Dastidar. “While we continue to build on the success of AI100 in India, 2023 is the year SigTuple will go global - with expansions planned across key markets in Southeast Asia, Middle East and North Africa, North America and Europe. ” Since 2020, the company has been focused on its core product, AI100, which automates the job of a pathologist by studying microscopic images of blood samples, interpreting them and issuing reports. The product, based on machine learning and artificial intelligence (AI), is being used by diagnostic laboratories and hospitals. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories Ramesh Byrapaneni, managing director, Endiya Partners, said, “SigTuple is solving an important problem by combining state-of-the-art digitisation and AI technology for peripheral blood smears and urine samples, the two most common tests in pathology labs worldwide. ” The company said it has onboarded two of the largest medical device distributors as channel partners for sales and service in India – Horiba Medical and Genworks Health – and it has expanded internationally to Indonesia. Partnerships and product launches are also planned in other countries. “SigTuple's digital solutions are at the forefront of innovation, and their dedication to enhancing patient outcomes is truly remarkable," said Barath Shankar Subramanian, partner at Accel. Don’t miss out on ET Prime stories! Get your daily dose of business updates on WhatsApp. click here! Wednesday, 01 Mar, 2023 Experience Your Economic Times Newspaper, The Digital Way! Read Complete Print Edition » Front Page Pure Politics Companies Brands & Companies More Economy Grows at a Slower Pace of 4. 4% in Dec qtr The Indian economy grew at a slower-than-expected 4. 4% in the December quarter compared with 6. 3% in the preceding three-month period, weighed down by base normalisation and weakness in consumption. Hope It Doesn’t Take a Second Pandemic to Build Right Tools The world needs to build more tools and global institutions to tackle any future pandemic, Bill Gates, cofounder of Microsoft and co-chair of the Bill & Melinda Gates Foundation, said in an interview to ET’s Deborshi Chaki. SAP to Double India Investment in 5yrs India is “a winner” and “a bright spot” in a world that’s in turmoil, says Christian Klein, chief executive at SAP SE. The German software giant aims to double its investments in India over the next five years. Read More News on sigtuple funding startup funding healthcare startup endiya partners accel ai100 sigtuple medical device distributors pathologist automation accel Stay on top of technology and startup news that matters. Subscribe to our daily newsletter for the latest and must-read tech news, delivered straight to your inbox. . . . more less ETPrime stories of the day People Meet Avadhut Sathe — the man on a mission to make every Indian wealthy via stock trading 13 mins read 3 insights to kick-start your day, featuring Wipro hunting for business 3 mins read Strategy Stock Radar: This auto component maker may retest 52-week highs in 2 months; should you buy? 3 mins read Subscribe to ETPrime.